临床规模稳定和可预测的隐形病毒载体生产
Niels Heinz1, Laura Mosbacher1, Lisa C Cordie1
1BioNTech-IMFS, Idar-Oberstein, Germany.
Human gene therapy
|November 21, 2025
概括
基因治疗的稳定晶状病毒载体生产现在可以通过新型EL1-820包装细胞系. 该系统确保可预测,可扩展和经济高效的临床应用治疗载体的制造.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 病毒载体对于基因疗法至关重要,因为它们的安全性和转导非分裂细胞的能力.
- 目前用于临床级别的隐形病毒载体的短暂生产方法不是可扩展的或具有成本效益的.
- 需要稳定,强大和可预测的lentiviral向量制造解决方案.
研究的目的:
- 设计,生成和表征EL1-820,一种用于稳定的lentiviral载体生产的新型包装细胞系.
- 为了实现有效和可靠的载体制造,用于临床应用.
- 建立一个可扩展和具有成本效益的替代临时生产方法.
主要方法:
- 开发EL1-820包装细胞系用于lentiviral自失活化 (SIN) 载体.
- 利用Flp-重组酶介导的磁带交换 (RMCE) 进行向量表达磁带的有针对性的集成.
- 具有特征的EL1-820生产者克隆用于矢量标位和生产可扩展性.
主要成果:
- 在EL1-820中,可以实现稳定,单复制的lentiviral转移载体 (lenti-GFP,lenti-CAR) 集成.
- 在最初的实验中,获得了与短暂产生的可比标位 (1 × 10^7 TU/mL).
- 证明了可扩展性,生物反应器收获产量为8-9 × 10^7 TU/mL,总产量为2.3 × 10^11 TU.
结论:
- 基于RMCE的矢量构造的引入有助于稳定,定义和可预测的lentiviral矢量生成.
- 细胞系EL1-820为临床级别的lentiviral载体制造提供了一个安全和合适的平台.
- 这种方法解决了短暂生产的局限性,为改进的基因治疗应用铺平了道路.
更多相关视频
16:04A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells
Published on: June 19, 2013
15.0K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10.3K
相关概念视频
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...